{
  "id": 16935113,
  "title": "Human Dengue Study Reveals How Preexisting Immunity Shapes Secondary Infections",
  "url": "https://urgent.news/2026/10/28/human-dengue-study-reveals-how-preexisting-immunity-shapes-secondary",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-28T18:00:01.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/infectious-diseases/human-dengue-study-reveals-how-preexisting-immunity-shapes-secondary-infections/"
  },
  "original_language": "en",
  "account": "An estimated 100-400 million people contract dengue, also known as break-bone fever, each year, posing a significant health threat to roughly half of the world's population. Dengue is prevalent in tropical and subtropical regions, and prevention primarily involves controlling the mosquito vector that transmits the virus. A new Phase I trial provides insights into how preexisting immunity and anti-dengue antibodies impact the severity of secondary dengue infections. The study, published in Science Translational Medicine, reveals that individuals with antibodies that boost viral replication experience higher viral counts, reduced CD8-bearing T cells, and stronger acute immune responses. Conversely, those with antibodies against the viral nonstructural protein 1 display more balanced immune responses, leading to better control of viremia and the development of enduring, potent B and T cells. These findings could inform the development of broadly protective vaccines that induce long-lasting dengue immunity.",
  "summary": "A controlled human trial reveals how preexisting antibodies influence dengue virus replication and immune responses, offering insights to develop safer, more broadly protective vaccines against all four dengue strains. The post Human Dengue Study Reveals How Preexisting Immunity Shapes Secondary Infections appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [
    "Preexisting immunity impacts dengue severity.",
    "Antibodies boosting viral replication cause higher viral counts.",
    "Antibodies against NS1 protein lead to balanced immune responses."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}